For the year ending 2025-12-31, APGE has $937,134K in assets. $33,251K in debts.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 131,549 | |||
| Marketable securities | 598,643 | |||
| Prepaid expenses and other current assets | 11,166 | |||
| Total current assets | 741,358 | |||
| Long-term marketable securities | 172,730 | |||
| Property and equipment, net | 5,688 | |||
| Right-of-use asset, net | 8,687 | |||
| Other non-current assets | 8,671 | |||
| Total assets | 937,134 | |||
| Accounts payable | 1,221 | |||
| Lease liability | 3,504 | |||
| Accrued expenses and other current liabilities | 23,181 | |||
| Total current liabilities | 27,906 | |||
| Lease liability, net of current | 5,345 | |||
| Total liabilities | 33,251 | |||
| Common stock 0.00001 par value, 400,000,000 authorized, 69,038,943 issued and 68,401,349 outstanding as of december 31, 2025 400,000,000 authorized, 59,478,725 issued and 58,062,898 outstanding as of december 31, 2024 | 1 | |||
| Additional paid-in capital | 1,464,561 | |||
| Accumulated other comprehensive income | 1,080 | |||
| Accumulated deficit | -561,759 | |||
| Total stockholders' equity | 903,883 | |||
| Total liabilities and stockholders' equity | 937,134 | |||
Apogee Therapeutics, Inc. (APGE)
Apogee Therapeutics, Inc. (APGE)